Skip to main content
. 2020 Aug 28;18(3):2142. doi: 10.18549/PharmPract.2020.3.2142

Figure 1. Proposed structure for pharmaceutical services on the multimorbidity care model.

Figure 1

G0: null or unknown risk; G1: low risk; G2: intermediate risk; G3: high risk.